Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines : Questions médicales fréquentes
Nom anglais: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
Descriptor UI:D051778
Tree Number:D12.776.930.127.092
Termes MeSH sélectionnés :
Lithium Compounds
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines : Questions médicales les plus fréquentes",
"headline": "Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-09",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteurs de transcription à motif basique et à glissière à leucines",
"url": "https://questionsmedicales.fr/mesh/D050976",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de transcription à motif basique et à glissière à leucines",
"code": {
"@type": "MedicalCode",
"code": "D050976",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.127"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteur de transcription associé à la microphtalmie",
"alternateName": "Microphthalmia-Associated Transcription Factor",
"url": "https://questionsmedicales.fr/mesh/D051739",
"about": {
"@type": "MedicalCondition",
"name": "Facteur de transcription associé à la microphtalmie",
"code": {
"@type": "MedicalCode",
"code": "D051739",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.127.092.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine du proto-oncogène N-Myc",
"alternateName": "N-Myc Proto-Oncogene Protein",
"url": "https://questionsmedicales.fr/mesh/D000071447",
"about": {
"@type": "MedicalCondition",
"name": "Protéine du proto-oncogène N-Myc",
"code": {
"@type": "MedicalCode",
"code": "D000071447",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.127.092.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines de liaison à l'élément de régulation des stérols",
"alternateName": "Sterol Regulatory Element Binding Proteins",
"url": "https://questionsmedicales.fr/mesh/D051779",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de liaison à l'élément de régulation des stérols",
"code": {
"@type": "MedicalCode",
"code": "D051779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.127.092.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine-1 de liaison à l'élément de régulation des stérols",
"alternateName": "Sterol Regulatory Element Binding Protein 1",
"url": "https://questionsmedicales.fr/mesh/D051780",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-1 de liaison à l'élément de régulation des stérols",
"code": {
"@type": "MedicalCode",
"code": "D051780",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.127.092.750.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-2 de liaison à l'élément de régulation des stérols",
"alternateName": "Sterol Regulatory Element Binding Protein 2",
"url": "https://questionsmedicales.fr/mesh/D051782",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-2 de liaison à l'élément de régulation des stérols",
"code": {
"@type": "MedicalCode",
"code": "D051782",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.127.092.750.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Facteur-3 de transcription",
"alternateName": "Transcription Factor 3",
"url": "https://questionsmedicales.fr/mesh/D058127",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-3 de transcription",
"code": {
"@type": "MedicalCode",
"code": "D058127",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.127.092.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines",
"alternateName": "Basic Helix-Loop-Helix Leucine Zipper Transcription Factors",
"code": {
"@type": "MedicalCode",
"code": "D051778",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Muhammad Waseem",
"url": "https://questionsmedicales.fr/author/Muhammad%20Waseem",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Plant Hormones and Development Regulation of Chongqing, School of Life Sciences, Chongqing University, Chongqing, China."
}
},
{
"@type": "Person",
"name": "Zhengguo Li",
"url": "https://questionsmedicales.fr/author/Zhengguo%20Li",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Plant Hormones and Development Regulation of Chongqing, School of Life Sciences, Chongqing University, Chongqing, China."
}
},
{
"@type": "Person",
"name": "Bao-Teng Wang",
"url": "https://questionsmedicales.fr/author/Bao-Teng%20Wang",
"affiliation": {
"@type": "Organization",
"name": "College of Biology and the Environment, Co-Innovation Center for Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, China."
}
},
{
"@type": "Person",
"name": "Miao Zhuang",
"url": "https://questionsmedicales.fr/author/Miao%20Zhuang",
"affiliation": {
"@type": "Organization",
"name": "College of Biology and the Environment, Co-Innovation Center for Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, China."
}
},
{
"@type": "Person",
"name": "Zhi-Min Zhang",
"url": "https://questionsmedicales.fr/author/Zhi-Min%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "College of Biology and the Environment, Co-Innovation Center for Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Lithium Therapy in Old Age: Recommendations from a Delphi Survey.",
"datePublished": "2023-07-28",
"url": "https://questionsmedicales.fr/article/37506737",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2117-5200"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lithium increases cortical and subcortical volumes in subjects with bipolar disorder.",
"datePublished": "2022-05-21",
"url": "https://questionsmedicales.fr/article/35640450",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pscychresns.2022.111494"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36253798",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40246-022-00418-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lithium treatment versus hospitalization in bipolar disorder and major depression patients.",
"datePublished": "2023-08-07",
"url": "https://questionsmedicales.fr/article/37557990",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.08.028"
}
},
{
"@type": "ScholarlyArticle",
"name": "Demographic and clinical characteristics of lithium-treated older adults with bipolar disorder.",
"datePublished": "2022-07-26",
"url": "https://questionsmedicales.fr/article/35837985",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/acps.13474"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs de transcription",
"item": "https://questionsmedicales.fr/mesh/D014157"
},
{
"@type": "ListItem",
"position": 5,
"name": "Facteurs de transcription à motif basique et à glissière à leucines",
"item": "https://questionsmedicales.fr/mesh/D050976"
},
{
"@type": "ListItem",
"position": 6,
"name": "Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines",
"item": "https://questionsmedicales.fr/mesh/D051778"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines",
"description": "Comment diagnostiquer une anomalie des facteurs de transcription ?\nQuels tests sont utilisés pour évaluer ces facteurs ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nPeut-on détecter ces facteurs dans le sang ?\nQuels marqueurs sont associés à ces facteurs ?",
"url": "https://questionsmedicales.fr/mesh/D051778?mesh_terms=Lithium+Compounds&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines",
"description": "Quels symptômes sont liés aux dysfonctionnements de ces facteurs ?\nLes symptômes varient-ils selon le type de facteur ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes apparaissent-ils à un âge spécifique ?\nLes symptômes sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D051778?mesh_terms=Lithium+Compounds&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines",
"description": "Comment prévenir les anomalies des facteurs de transcription ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes vaccinations peuvent-elles aider ?\nLe dépistage prénatal est-il utile ?\nY a-t-il des recommandations pour les femmes enceintes ?",
"url": "https://questionsmedicales.fr/mesh/D051778?mesh_terms=Lithium+Compounds&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines",
"description": "Quels traitements sont disponibles pour les anomalies ?\nLa thérapie génique est-elle efficace ?\nDes traitements préventifs existent-ils ?\nLes médicaments peuvent-ils corriger les anomalies ?\nY a-t-il des essais cliniques en cours ?",
"url": "https://questionsmedicales.fr/mesh/D051778?mesh_terms=Lithium+Compounds&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines",
"description": "Quelles complications peuvent survenir avec ces anomalies ?\nLes complications sont-elles toujours graves ?\nY a-t-il des risques de complications à long terme ?\nLes complications peuvent-elles être évitées ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D051778?mesh_terms=Lithium+Compounds&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines",
"description": "Quels sont les facteurs de risque pour ces anomalies ?\nL'âge parental influence-t-il le risque ?\nLes habitudes de vie affectent-elles le risque ?\nY a-t-il des tests pour évaluer le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D051778?mesh_terms=Lithium+Compounds&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des facteurs de transcription ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses d'expression génique peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer ces facteurs ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'ADN et les techniques de PCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Parfois, des biopsies peuvent être nécessaires pour évaluer l'expression des gènes."
}
},
{
"@type": "Question",
"name": "Peut-on détecter ces facteurs dans le sang ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, ils sont évalués dans des échantillons de tissus plutôt que dans le sang."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés à ces facteurs ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs spécifiques de l'expression génique peuvent indiquer des anomalies."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux dysfonctionnements de ces facteurs ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles du développement, des anomalies métaboliques ou des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de facteur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type de facteur de transcription impliqué."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de croissance ou des troubles hormonaux peuvent être des indicateurs."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à un âge spécifique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent apparaître à la naissance, d'autres plus tard dans l'enfance."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la nature de l'anomalie et du traitement appliqué."
}
},
{
"@type": "Question",
"name": "Comment prévenir les anomalies des facteurs de transcription ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par le conseil génétique et la détection précoce."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé génétique, mais ne prévient pas toutes les anomalies."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas directement les anomalies génétiques."
}
},
{
"@type": "Question",
"name": "Le dépistage prénatal est-il utile ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage prénatal peut identifier certaines anomalies génétiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les femmes enceintes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes enceintes devraient suivre des soins prénatals réguliers et un bon mode de vie."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les anomalies ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des thérapies géniques ou des médicaments ciblés."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être efficace pour certaines anomalies génétiques, mais pas pour toutes."
}
},
{
"@type": "Question",
"name": "Des traitements préventifs existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conseils génétiques peuvent aider à prévenir certaines anomalies héréditaires."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils corriger les anomalies ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent cibler les voies de signalisation affectées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques en cours ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux essais cliniques explorent de nouvelles thérapies pour ces anomalies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces anomalies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des troubles métaboliques ou des cancers."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles toujours graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certaines anomalies peuvent être gérées avec succès."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies peuvent entraîner des complications chroniques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent avoir un impact significatif sur la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour ces anomalies ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines expositions environnementales sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge parental influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé des parents peut augmenter le risque d'anomalies génétiques."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie affectent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie saines peuvent réduire certains risques d'anomalies."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests pour évaluer le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent évaluer le risque d'anomalies héréditaires."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines substances chimiques peut augmenter le risque."
}
}
]
}
]
}
While lithium (Li) has been well established for the treatment of bipolar disorder, geriatric patients require special attention when it comes to issues of drug safety. Declining renal function, among...
Twenty-four German medical experts on geriatric medicine and Li treatment participated in a Delphi survey, consisting of two rounds of questionnaires and a final formulation of treatment recommendatio...
Final consensus was achieved on 21 clinical recommendations. The approved recommendations covered aspects of necessary laboratory checks, concomitant medication, and target Li serum concentration in g...
According to the view of German experts, Li may be used in geriatric patients, but it should be monitored carefully. However, the lack of consent in several specific treatment situations underlines th...
Bipolar disorder (BD) is a highly variable and burdensome disease for patients and caregivers. A BD diagnosis almost triples the likelihood of developing dementia as the disease progresses. Neurocogni...
It has been suggested that bipolar disorder (BD) is associated with clinical and biological features of accelerated aging. In our previous studies, we showed that long-term lithium treatment was corre...
There was no difference in TL between BD patients and HC. Moreover, LiCl did not influence TL in the overall sample, and there was no difference between diagnostic or clinical response groups. Likewis...
Our findings suggest that a 7-day lithium treatment protocol and the use of LCLs might not represent a suitable approach to deepen our understanding on the role of altered telomere dynamics in BD as p...
Preventing hospitalization of major affective disorder patients is a fundamental clinical challenge for which lithium is expected to be helpful....
We compared hospitalization rates and morbidity of 260 patients with DSM-5 bipolar or major depressive disorder in the 12 months before starting lithium versus 12 months of its use. We evaluated durat...
Within 12 months before lithium, 40.4 % of patients were hospitalized versus 11.2 % during lithium treatment; other measures of morbidity also improved. Benefits were similar with bipolar and major de...
Participants and observation times were limited. The study was retrospective regarding clinical history, lacked strict control of treatments and was not blinded....
This naturalistic study adds support to the effectiveness of lithium treatment in preventing hospitalization in patients with episodic major mood disorders....
There is limited information on the characteristics of older adults with bipolar disorder (OABD) treated with lithium, along with safety concerns about its use by older adults. The aim of the present ...
Cross-sectional analysis of the GAGE-BD dataset to determine differences and similarities between lithium users and non-users. We analysed data from 986 participants aged 50 years or older (mean age 6...
OABD treated with lithium had lower scores on depression rating scales and were less likely to be categorised as with moderate or severe depression. There was a lower proportion of lithium users than ...
We found several potentially relevant differences in the clinical profile of OABD treated with lithium compared with those treated with other mood stabilisers. However, the interpretation of the prese...
Bipolar Disorder (BD) represents the seventh major cause of disability life-years-adjusted. Lithium remains as a first-line treatment, but clinical improvement occurs only in 30 % of treated patients....
We used machine-learning techniques (Advance Recursive Partitioned Analysis, ARPA) to build a personalized prediction framework of BD lithium response using biological, clinical, and demographical dat...
The predictive model including ancestry yield the best performance (sensibility = 84.6 %, specificity = 93.8 % and AUC = 89.2 %) compared to the model without ancestry (sensibility = 50 %, Specificity...
Ancestry component is a major predictor and significantly improves the definition of individual Lithium response in BD patients. We provide classification trees with potential bench application in the...
Lithium is a cornerstone in the treatment of bipolar disorder and is considered one of the most effective treatments in psychiatry at large. Lithium treatment requires individual dosing with frequent ...
Laboratory: Capillary blood was sampled by finger-prick using a volumetric device that collects 10 µL volumes as a dried blood spot. Lithium was measured in the dried blood spots using a validated ato...
Thirty-nine lithium-treated patients were recruited, and dried blood spots and venous blood samples were collected. Routine serum analysis was performed for comparison....
The range of serum lithium concentrations was 0.41-1.22 mmol/L, and the dried blood spot/serum ratio was 0.78. A strong linear correlation between the two specimens was shown with Pearson's R = 0.95 (...
Volumetric dried blood spots is a promising technique for measurement of lithium concentrations. This will enable home-sampling and could potentially save resources, improve compliance, and make treat...
Lithium (Li) is recommended for long-term treatment of bipolar disorder (BD). However, its mechanism of action is still poorly understood. Induced pluripotent stem cell (iPSC)-derived brain organoids ...
Clinical guidelines recommend monitoring of creatinine and lithium throughout treatment with lithium. We here assessed the extent to which this occurs in healthcare in Sweden....
This is an observational study of all adults with bipolar disorder starting lithium therapy in Stockholm, Sweden, during 2007-2018. The main outcome was monitoring of blood lithium and creatinine at t...
We identified 4428 adults with bipolar disorder who started lithium therapy and were followed up for up to 11 years. Their median age was 39 years, and 63% were women. The median duration on lithium t...
In a Swedish community sample, lithium and creatinine monitoring was inconsistent with guideline recommendations that call for measurement of annual biomarker levels....
Lithium carbonate is commonly used in the treatment of bipolar disorder. A spectrum of side effects is associated with lithium, including nephrogenic diabetes insipidus, renal tubular acidosis, chroni...
We herein report a case of lithium therapy-induced minimal change disease with concurrent chronic tubulointerstitial nephropathy. A 66-year old man with bipolar disorder treated by lithium for 20 year...
Based on the previously reported cases and review of literature, occurrence of lithium-associated minimal change nephropathy is rare. Patients with lithium-associated minimal change disease and acute ...